Avecho Biotechnology Limited Stock

Equities

AVE

AU0000047441

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:53 2024-05-31 am EDT 5-day change 1st Jan Change
0.003 AUD -25.00% Intraday chart for Avecho Biotechnology Limited -.--% -14.29%
Sales 2022 1.13M 751K Sales 2023 474K 315K Capitalization 11.09M 7.38M
Net income 2022 -2M -1.33M Net income 2023 -3M -2M EV / Sales 2022 23.3 x
Net cash position 2022 1.22M 813K Net cash position 2023 5.33M 3.55M EV / Sales 2023 12.2 x
P/E ratio 2022
-11.5 x
P/E ratio 2023
-2.31 x
Employees 15
Yield 2022 *
-
Yield 2023
-
Free-Float 65.6%
More Fundamentals * Assessed data
Dynamic Chart
1 day-25.00%
1 month-25.00%
Current year-14.29%
More quotes
1 week
0.00
Extreme 0.003
0.00
1 month
0.00
Extreme 0.003
0.00
Current year
0.00
Extreme 0.003
0.01
1 year
0.00
Extreme 0.003
0.01
3 years
0.00
Extreme 0.003
0.02
5 years
0.00
Extreme 0.002
0.05
10 years
0.00
Extreme 0.002
0.11
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01-12-31
Director of Finance/CFO 51 18-12-27
Chief Operating Officer - 00-12-31
Members of the board TitleAgeSince
Director/Board Member - 15-01-13
Director/Board Member 60 20-01-12
Chairman - 15-04-12
More insiders
Date Price Change Volume
24-05-31 0.003 -25.00% 479,690
24-05-30 0.004 +33.33% 121,429
24-05-29 0.003 -25.00% 390,836
24-05-28 0.004 +33.33% 472,909
24-05-27 0.003 -.--% 1,804

Delayed Quote Australian S.E., May 31, 2024 at 02:10 am EDT

More quotes
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
More about the company